Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery

References

• Chi SC, Yeom DI, Kim SC, Park ES. A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate. Arch Pharm Res 2003; 26: 173–81
   PubMed Web of Science ®Google Scholar
• Chen ZP, Zhu JB, Chen HX, Xiao YY, Chen J, Cai BC. Distribution of liposomal bifendate in liver following intravenous injection in mice. J Drug Target 2010; 18: 627–36
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev 2008; 60: 757–67
   PubMed Web of Science ®Google Scholar
• Cui S, Wang M, Fan G. Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study. Zhonghua Yi Xue Za Zhi 2002; 82: 538–40
   PubMedGoogle Scholar
• El-Sawy SA, El-Shafey AM, El-Bahrawy HA. Effect of dimethyl diphenyl bicarboxylate on normal and chemically-injured liver. East Mediterr Health J 2002; 8: 95–104
   PubMedGoogle Scholar
• Gao Y, Li Z, Sun M, Li H, Guo C, Cui J, Li A, Cao F, Pei Y, Cao F, et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm 2010; 36(10)1225–34
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M, Duan C, Dai W, Jia L, Zhao W. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int J Pharm 2008; 355: 321–7
   PubMed Web of Science ®Google Scholar
• Hecq J, Deleers M, Fanara D, Vranckx H, Boulanger P, Le Lamer S, Amighi K. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. Eur J Pharm Biopharm 2006; 64: 360–8
   PubMed Web of Science ®Google Scholar
• Hyun J, Chun IK. Dissolution characteristics of biphenyl dimethyl dicarboxylate from solid dispersion and permeation through rabbit duodenal mucosa. J Korean Pharm Sci 1994; 24: 57–65
   Google Scholar
• Illig KJ, Mueller RL, Ostrander KD, Swanson JR. Use of microfluidizer processing for preparation of pharmaceutical suspensions. Pharm Technol 1996; 20: 78–88
   Google Scholar
• Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 2006; 62: 3–16
   PubMed Web of Science ®Google Scholar
• Kwon JT, Hwang SK, Jin H, Kim DS, Minai-Tehrani A, Yoon HJ, Choi M, Yoon TJ, Han DY, Kang YW, et al. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 2008; 50: 1–6
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim JR, Lee CH. Effect of 2-methylaminoethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2-car boxylic acid-2'-carboxylate monohydrochloride (DDB-S) on indocyanine green (ICG) clearance in rats. Arch Pharm Res 2005; 28: 115–19
   PubMed Web of Science ®Google Scholar
• Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis 1982; 41: 263–7
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001; 53: 283–318
   PubMed Web of Science ®Google Scholar
• Qi X, Wang X, Wang L, Wang Q, Cheng S, Suo J, Chang J. A solid-phase approach to DDB derivatives. Eur J Med Chem 2005; 40: 805–10
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004; 3: 785–96
   PubMed Web of Science ®Google Scholar
• Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterisation and in vivo evaluation. J Controlled Release 2001; 70: 353–63
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology 2010; 21: 155104
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Watanabe K, Hayashi M, Awazu S. Effect of egg yolk phospholipids plasma elimination and tissue distribution of coenzyme Q10 administered in an emulsion to rats. J Pharm Pharmacol 1984; 36: 766–7
   PubMed Web of Science ®Google Scholar
• Yao J, Zhou JP, Ping QN, Lu Y, Chen L. Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int J Pharm 2008; 352: 256–62
   PubMed Web of Science ®Google Scholar
• Zhao YX, Hua HY, Chang M, Liu WJ, Zhao Y, Liu HM. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions. Int J Pharm 2010; 392: 64–71
   PubMed Web of Science ®Google Scholar